Drug Design Development and Therapy
Methodological Considerations on the Cumulative Folic Acid Dose Threshold and Incident Diabetes in Coronary Heart Disease [Letter]
By Jia‐ying Li and Li Ning.
Abstract
Jiaying Li,1,2 Ning Li21School of Nursing, Zhejiang Chinese Medical University, Hangzhou, People’s Republic of China; 2Nursing Department, Hangzhou First People’s Hospital, Hangzhou, People’s Republic of ChinaCorrespondence: Ning Li, Nursing Department, Hangzhou First People’s Hospital, Hangzhou, People’s Republic of China, Email nl5401@163.com
Keywords
- Folate and B Vitamins Research
- folic acid
- new-onset diabetes
- coronary artery disease
- folic acid supplementation
- diabetes risk
- Open access
Source
Published in Drug Design Development and Therapy. The abstract is shown as published and remains the work of its authors; read the full article at the source.
Prognia lists this article for reference and education. It is not medical advice. Always read the original and follow current guidelines and local protocols before acting on it.
At a glance
More in endocrinology and metabolism
- Molecular mechanisms underlying the effectiveness of triiodothyroacetic acid (Triac) in patients with resistance to thyroid hormone β (RTHβ): a multicentre, international, retrospective cohort studyEBioMedicine · 2026
- Cholestatic Liver Injury following Re-initiation of Carbimazole in a Patient with Graves’ Disease: A Case ReportJournal of Clinical and Diagnostic Research · 2026
